当前位置: X-MOL 学术Neuroimage Clin. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dual-phase 18F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer’s disease
NeuroImage: Clinical ( IF 3.4 ) Pub Date : 2021-07-24 , DOI: 10.1016/j.nicl.2021.102773
Hai-Jeon Yoon 1 , Bom Sahn Kim 1 , Jee Hyang Jeong 2 , Geon Ha Kim 2 , Hee Kyung Park 3 , Min Young Chun 2 , Seunggyun Ha 4
Affiliation  

Background

This study investigated changes in brain perfusion and Aβ burden according to the progression of Alzheimer’s disease (AD) by using a dual-phase 18F-florbetaben (FBB) PET protocol.

Methods

Sixty subjects, including 12 with Aβ-negative normal cognition (AβNC), 32 with Aβ-positive mild cognitive impairment (Aβ+MCI), and 16 with Aβ-positive AD (Aβ+AD), were enrolled. A dynamic PET scan was obtained in the early phase (0–10 min, eFBB) and delayed phase (90–110 min, dFBB), which were then averaged into a single frame, respectively. In addition to the averaged eFBB, an R1 parametric map was calculated from the eFBB scan based on a simplified reference tissue model (SRTM). Between-group regional and voxel-wise analyses of the images were performed. The associations between cognitive profiles and PET-derived parameters were investigated.

Results

Both the R1 and eFBB perfusion reductions in the cortical regions were not significantly different between the AβNC and Aβ+MCI groups, while they were significantly reduced from the Aβ+MCI to Aβ+AD groups in regional and voxel-wise analyses. However, cortical Aβ depositions on dFBB were not significantly different between the Aβ+MCI and Aβ+AD groups. There were strong positive correlations between the R1 and eFBB images in regional and voxel-wise analyses. Both perfusion components showed significant correlations with general and specific cognitive profiles.

Conclusion

The results of this study demonstrated the feasibility of dual-phase 18F-FBB PET to evaluate different trajectories of dual biomarkers for neurodegeneration and Aβ burden over the course of AD. In addition, both eFBB and SRTM-based R1 can provide robust indices of brain perfusion.



中文翻译:

双相 18F-florbetaben PET 提供脑灌注代理以及阿尔茨海默病中的 β-淀粉样蛋白负荷

背景

本研究使用双相18 F-florbetaben (FBB) PET 协议,根据阿尔茨海默病 (AD) 的进展调查了脑灌注和 Aβ 负荷的变化。

方法

60名受试者,包括12名Aβ阴性正常认知(Aβ - NC),32名Aβ阳性轻度认知障碍(Aβ + MCI)和16名Aβ阳性AD(Aβ + AD)。在早期阶段(0-10 分钟,eFBB)和延迟阶段(90-110 分钟,dFBB)获得动态 PET 扫描,然后分别平均为一个帧。除了平均 eFBB 之外,R1 参数图还根据基于简化参考组织模型 (SRTM) 的 eFBB 扫描计算得出。对图像进行组间区域和体素分析。研究了认知特征和 PET 衍生参数之间的关联。

结果

皮质区域的 R1 和 eFBB 灌注减少在 Aβ - NC 和 Aβ + MCI 组之间没有显着差异,而在区域和体素分析中,它们从 Aβ + MCI 到 Aβ + AD 组显着减少。然而,dFBB 上的皮质 Aβ 沉积在 Aβ + MCI 和 Aβ + AD 组之间没有显着差异。在区域和体素分析中,R1 和 eFBB 图像之间存在很强的正相关性。两种灌注成分都显示出与一般和特定认知特征的显着相关性。

结论

这项研究的结果证明了双相18 F-FBB PET 评估 AD 过程中神经变性和 Aβ 负荷的双重生物标志物的不同轨迹的可行性。此外,eFBB 和基于 SRTM 的 R1 都可以提供强大的脑灌注指数。

更新日期:2021-07-30
down
wechat
bug